A discussion with the most prominent and leading scientists at the forefront of Substance Use Disorder (SUD) and mental health research was held. Our forum was a unique opportunity to learn about the latest advances to stop this devastating disease.

I. Welcome: Nancy Davis, Founder and President of CAN

II. Moderator and Introduction of Panel: Kurt Rasmussen, Ph.D., CSO Delix Therapeutics and Scientific Advisory Board, Chair for Cure Addiction Now

III. Living with substance use disorder: Lisa Vidal, Guest Panelist and Advocate

IV. Topics

1. Need for Innovation in the Treatment of Substance Use Disorders: Kelly E. Dunn, Ph.D., Johns Hopkins University School of Medicine
2. Focused Ultrasound Neuromodulation as an Adjunctive Treatment Strategy for SUD: James J. Mahoney, III, Ph.D., Rockefeller Neuroscience Institute, WVU Medicine
3. Ketamine in the ED as a Way to Help Treat Precipitated and/or Unmanaged Opioid Withdrawal: Andrew A Herring, MD, PI Bridge Center, Public Health Institute
4. Semaglutide (Ozempic) as a Potential Treatment for Alcohol Use Disorder: Christian Hendershot, Ph.D., Keck School of Medicine of USC
5. Tezampanel: A New Medication for Opiate Withdrawal: Christopher Toombs, Ph.D., DABT, co-Founder and Chief Scientific Officer for Proniras Corporation
6. Cimetidine as a Potential Therapeutic to Reduce Fentanyl Withdrawal Severity: Cassandra D. Gipson-Reichardt, Ph.D., University of Kentucky
7. Scientists are Creating More Paths to Success for Individuals with Substance Use Disorders: Cecilia Bergeria, Ph.D., Johns Hopkins University School of Medicine
8. Vaccines and Monoclonal Antibodies as Treatments for Opioid Use Disorder and Opioid Overdose: Sandra Comer, Ph.D., Columbia University Irving Medical Center
9. Evaluating Suvorexant for Persons Who use Both Opioids and Cocaine - Feasibility and Lessons Learned: Jennifer Ellis, Ph.D., Johns Hopkins School of Medicine
10. Public Health Policy and SUD: Adam Kaplin, M.D, Ph.D., CSO MyMD Pharmaceuticals

IV. Lightning Round: Answers to Submitted Questions

V. Conclusion and Thank You by Nancy Davis